Athira Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.75
|
|
Average Rating
|
3.83
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.63
|
-0.53
|
0.10
|
15.87%
|
|
2022-06-30
|
-0.64
|
-0.65
|
-0.01
|
-1.56%
|
|
2022-03-31
|
-0.55
|
-0.56
|
-0.01
|
-1.82%
|
|
2021-12-31
|
-0.54
|
-0.45
|
0.09
|
16.67%
|
|
2021-09-30
|
-0.50
|
-0.42
|
0.08
|
16.00%
|
|
2021-06-30
|
-0.34
|
-0.38
|
-0.04
|
-11.76%
|
|
2021-03-31
|
-0.30
|
-0.25
|
0.05
|
16.67%
|
|
2020-12-31
|
-0.40
|
-0.24
|
0.16
|
40.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.74
|
|
2021-12-31
|
-1.50
|
|
2020-12-31
|
-1.80
|